comparemela.com

Acurx Pharmaceuticals (ACXP) Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection

Acurx Pharmaceuticals (ACXP) Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States ,Robertj Deluccia , ,Trial Oversight Committee ,Nasdaq ,Drug Administration ,Data Monitoring Committee ,Acurx Pharmaceuticals Inc ,Company Scientific Advisory Board ,Acurx Pharmaceuticals ,Advice Meeting ,Modified Intent To Treat ,Clinical Cure ,Executive Chairman ,New Drug Application ,Marketing Authorizations ,Ibezapolstat Phase ,Scientific Advisory Board ,Modified Intent ,Treat Population ,Per Protocol Population ,Prescribing Information ,Independent Data Monitoring Committee ,Fast Track Designated ,Gram Positive Selective Spectrum ,Qualified Infectious Disease Product ,Generating New Antibiotic Incentives Now ,

comparemela.com © 2020. All Rights Reserved.